Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution

Cancer types prostate


C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel

International Journal of Radiation Oncology Biology Physics
September 1, 2008
Dr. Platta from the University of Wisconsin describes the outcomes of 67 patients treated with Cesium-131 prostate brachytherapy. He reports that the rate of PSA decline following treatment with Cesium-131 may be faster than for other brachytherapy radioisotopes. Because of the quick resolution of urinary side effects, Dr. Platta and his colleagues call for larger scale studies into Cesium-131 prostate brachytherapy.

Related posts

Scroll to top